| Primary Faculty |
|
|
| Scott Barnum, Ph.D. |
|
Role of complement in the central |
|
|
nervous system |
| Peter Burrows, Ph.D. |
|
B cells; developmentally regulated genes; |
|
|
isotype switching |
| David Chaplin, M.D., Ph.D. |
|
Secondary lymphoid tissue development |
| |
|
and function |
| Larry Gartland, Ph.D. |
|
Flowcytometry/cell sorting |
| Louis Justement, Ph.D. |
|
Lymphocyte activation, tyrosine kinases |
| |
|
and phosphatases |
| Janusz Kabarowski, Ph.D |
|
Lipid regulation of Inflammation |
| |
|
and immunity in Atherosclerosis |
| John Kearney, Ph.D |
|
B cells; idiotypes; hybridomas; transgenic |
| |
|
mice; immunoregulation |
| Hyung-Gyoon Kim, Ph.D. |
|
Murine models of Human AML |
| Christopher Klug, Ph.D. |
|
Hematopoietic stem cell development |
| Jiri Mestecky, M.D., Ph.D. |
|
Mucosal immunity; vaccines |
| Suzanne Michalek, Ph.D. |
|
Vaccine delivery systems; mucosal |
| |
|
immunity; inflammation; T-cells and cytokines |
| Zina Moldoveanu, Ph.D. |
|
Mucosal immunity, IgA, vaccines |
| Jan Novak, Ph.D. |
|
Immunoglobin glycosylation; IgA |
| |
|
nephropathy |
| Susan Rich, Ph.D. |
|
Regulation of T cell function |
| Mark Walter, Ph.D. |
|
X-ray crystallography; cytokine |
| |
|
structure/function |
| Allan Zajac, Ph.D. |
|
Anti-viral immunity; T-cell responses |
| |
|
|
| Secondary Faculty |
|
|
| Prescott Atkinson, M.D., Ph.D. |
|
Signal transduction in lymphocytes |
| Daniel Balkovetz, M.D., Ph.D. |
|
Epithelial Cell Biology; Microbial |
|
|
Interactions with Polarized Epithelia |
| Louis Bridges, Jr, M.D., Ph.D. |
|
Immunoglobulin gene expression; |
| |
|
rheumatoid arthritis |
| R. Pat Bucy, M.D., Ph.D. |
|
T-cell development; immune regulation |
| Robert Carter, M.D. |
|
Molecular mechanisms of control of |
| |
|
B lymphocyte responses |
| Irshad Chaudry, Ph.D. |
|
Cardiovascular/Immunological Alterations |
|
|
Following Trauma-Sepsis |
| Noel Childers, D.D.S., Ph.D. |
|
Oral immunization; dental caries |
| James Collawn, Ph.D. |
|
Cell surface receptors & epithelial |
| |
|
cell biology |
| Randall Davis, M.D. |
|
Lymphocyte development and mechanisms |
| |
|
of lymphomagenesis |
| Jeffrey Edberg, Ph.D. |
|
Immunology and rheumatology |
| Charles Elson III, M.D. |
|
Gastroenterology mucosal immunology |
| |
|
inflammatory bowel disease |
| James George, Ph.D. |
|
Molecular mechanisms of bone marrow |
| |
|
induced tolerance and allograft rejection |
| Vithal Ghanta, Ph.D. |
|
Tumor immunology; immune system/aging; |
| |
|
CNS immune system interactions |
| Yancey Gillespie, Ph.D. |
|
Neurosurgery |
| Louis Heck, Jr., M.D. |
|
Rheumatoid arthritis, JRA, new |
| |
|
immunotherapies for rheumatoid arthritis |
| Bruce Julian, M.D. |
|
IgA nephropathy, recurrent disease in renal |
|
|
allografts, erythropoiesis after renal transplantation |
| Judith Kapp, Ph.D. |
|
Immune regulation and transplantation |
| Robert Kimberly, M.D. |
|
Immunologic diseases and autoimmunity |
| William Koopman, M.D. |
|
Pathogenesis of immune disease |
| Hiromi Kubagawa, M.D. |
|
B cells; antibodies; Fc receptors; |
| |
|
immunoglobulin-like receptors |
| Robinna Lorenz, M.D., Ph.D. |
|
Cellular & molecular immunology of the |
| |
|
gastrointestinal tract |
| Mary MacDougall, Ph.D. |
|
|
| Michele Marron, Ph.D. |
|
Role of MHC class I molecules & CD8 T cells |
|
|
in pathogenesis of type 1 diabetes |
| John Mountz, M.D. |
|
Autoimmunity; soluble Fas; transgenic mice |
| Chander Raman, Ph.D. |
|
Lymphocyte activation, immune tolerance |
| |
|
and autoimmunity |
| Harry Schroeder, M.D., Ph.D. |
|
Developmential genetics; clinical |
| |
|
immunology |
| Martin Schwacha, Ph.D. |
|
Surgery |
| Judith Thomas, Ph.D. |
|
Transplantation |
| Casey Weaver, M.D. |
|
T-cell development |
|
|
|
|
|
|
|
|
|
